Hideaki Nonaka

Dr. Hideaki Nonaka serves as an Adjunct Fellow at the Institute for Molecular Bioscience (IMB), focusing on cardiovascular medicine and interventional cardiology. His research spans heart failure mechanisms, diagnostic imaging, and post-intervention outcomes, with a particular interest in translational medicine and clinical cardiology applications. Dr. Nonaka has contributed to studies on ventricular assist device complications, pulmonary injury biomarkers, and fractional flow reserve (FFR) diagnostic accuracy.

His work integrates clinical practice with experimental models, such as in vivo lung perfusion systems for ARDS research and ex vivo cardiac imaging tools. Key contributions include analyzing post-procedure complications like Guillain-Barré syndrome after transcatheter interventions and exploring novel parameters for predicting lung injury progression.

Dr. Nonaka’s research emphasizes bridging preclinical and clinical findings, particularly in critical care scenarios and structural heart disease. His recent studies (2023–2025) highlight advancements in cardiac valve implantation strategies, FFR-guided revascularization trials, and the diagnostic utility of cardiac imaging modalities.

• Major Projects: DECISION QFR trial, OCEAN-LAAC registry, in vivo lung perfusion platforms
• Key Themes: Cardiac device outcomes, pulmonary mechanics, FFR applications